APLISOL
INJECTION · TUBERCULIN PURIFIED PROTEIN DERIVATIVE 5 [iU]/.1mL
United StatesActive
Marketing holder: A-S Medication Solutions
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE · 5 [iU]/.1mL
Registration
- Registration number
- 50090-1336
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRADERMAL
Sources
- product · openFDA NDC · 50090-1336 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50090-1336 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50090-1336 · Verified 2026-10-09 · open in source